screen-mab-fto-risk-ls

【设计与创意】Conduct an evidence-backed freedom-to-operate risk screen for monoclonal antibodies, bispecific antibodies, and antibody-drug conjugates across user-selected markets. Use when a user provides antibody sequences or a defined biologic candidate and asks for patent clearance, claim coverage screening, jurisdiction-specific risk triage, or design-around …

独立 GitHub 快照 · 自动分类 · 以原作者文档为准